These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20041945)

  • 1. Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures.
    Krauss G; Ben-Menachem E; Mameniskiene R; Vaiciene-Magistris N; Brock M; Whitesides JG; Johnson ME;
    Epilepsia; 2010 Jun; 51(6):951-7. PubMed ID: 20041945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
    Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD
    Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial.
    Chung S; Sperling MR; Biton V; Krauss G; Hebert D; Rudd GD; Doty P;
    Epilepsia; 2010 Jun; 51(6):958-67. PubMed ID: 20132285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
    Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
    Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
    Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
    Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain.
    Harris JA; Murphy JA
    Ann Pharmacother; 2009 Nov; 43(11):1809-17. PubMed ID: 19843834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures.
    Biton V; Rosenfeld WE; Whitesides J; Fountain NB; Vaiciene N; Rudd GD
    Epilepsia; 2008 Mar; 49(3):418-24. PubMed ID: 17888078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
    Baulac M; Brodie MJ; Elger CE; Krakow K; Stockis A; Meyvisch P; Falter U
    Epilepsia; 2007 Mar; 48(3):589-92. PubMed ID: 17326794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
    Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
    Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lacosamide as adjunctive therapy for partial-onset epileptic seizures: a review of the clinical and economic literature.
    Simoens S
    Curr Med Res Opin; 2011 Jul; 27(7):1329-38. PubMed ID: 21561394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimizing pharmacodynamic interactions of high doses of lacosamide.
    Edwards HB; Cole AG; Griffiths AS; Lin B; Bean A; Krauss GL
    Acta Neurol Scand; 2012 Apr; 125(4):228-33. PubMed ID: 22070525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial.
    Shaibani A; Biton V; Rauck R; Koch B; Simpson J
    Eur J Pain; 2009 May; 13(5):458-63. PubMed ID: 18619874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.
    Rosenfeld W; Fountain NB; Kaubrys G; Ben-Menachem E; McShea C; Isojarvi J; Doty P;
    Epilepsy Behav; 2014 Dec; 41():164-70. PubMed ID: 25461210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacosamide: a review of its use as adjunctive therapy in the management of partial-onset seizures.
    Hoy SM
    CNS Drugs; 2013 Dec; 27(12):1125-42. PubMed ID: 24203890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid loading of intravenous lacosamide: efficacy and practicability during presurgical video-EEG monitoring.
    Li W; Stefan H; Matzen J; Rampp S; Heinze HJ; Schmitt FC
    Epilepsia; 2013 Jan; 54(1):75-80. PubMed ID: 22998639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence of intravenous and oral formulations of the antiepileptic drug lacosamide.
    Cawello W; Bonn R; Boekens H
    Pharmacology; 2012; 90(1-2):40-6. PubMed ID: 22722651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsy.
    Gavatha M; Ioannou I; Papavasiliou AS
    Epilepsy Behav; 2011 Apr; 20(4):691-3. PubMed ID: 21406334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.